Irvine, CA 的 癌症（所有類型） 臨床試驗
17 項針對 癌症（所有類型） 的研究正在 Irvine（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
招募中3 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 284734, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
招募中1 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
Statins to Prevent Cancer Associated Blood Clots
招募中4 期
- City of Hope, Irvine
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
招募中2 期
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Hoag Hospital Center, Irvine
- Hoag Hospital Irvine, Irvine
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Kaiser Permanente-Irvine, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
招募中1/2 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
招募中
- UCI Health Susan Samueli Integrative Health Institute, Irvine
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- City of Hope - Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Irvine
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
招募中1 期
- UC Irvine, Irvine
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
招募中
- University of California, Irvine, Irvine
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
其他城市的 癌症（所有類型） 試驗
- Houston, TX121 項研究
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
Irvine 的其他研究
- 非小細胞肺癌25 項研究
- 乳癌23 項研究
- 轉移性癌症16 項研究
- 肺癌15 項研究
- 多發性骨髓瘤14 項研究
- 前列腺癌14 項研究
- 卵巢癌12 項研究
- 頭頸部鱗狀細胞癌11 項研究
- 膀胱癌11 項研究
- 阿茲海默症11 項研究
- 大腸直腸癌10 項研究
- 胰臟癌10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。